Latest Capital Strategy News

The Alternative Investment Trust (AIQ) has extended its on-market buy-back of up to 10% of issued units, signaling continued capital management efforts amid steady market conditions.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.

Paradigm Biopharmaceuticals marked FY25 with the launch of its global Phase 3 trial for its osteoarthritis drug iPPS, backed by strong FDA protocol approval and a $41 million funding facility. The company also broadened its pipeline with the acquisition of Pentacoxib™, targeting early-stage OA.

Alligator Energy has lodged a Prospectus for Placement Options following its June 2025 capital raise, setting the stage for potential shareholder dilution and future funding opportunities.

Blue Energy Limited has successfully raised $3.2 million through a two-tranche placement, complemented by a proposed $250,000 share purchase plan, to fund drilling and pipeline development in Queensland’s North Bowen Basin.

NEXTDC has delivered record FY25 financial results, surpassing revenue and EBITDA guidance while aggressively expanding its data centre footprint across Australia and Asia-Pacific. The company’s strengthened liquidity and strategic investments position it to capitalise on soaring AI and cloud demand.

humm Group Limited reported a remarkable 458% increase in net profit for FY25, driven by strong asset growth and effective cost management. The company also announced a final dividend and highlighted ongoing technology transformation and ESG commitments.

Solvar Limited’s FY25 results highlight solid loan book growth in Australia, the strategic launch of Bennji commercial finance, and a significant 40% increase in dividends, underpinning confidence in future earnings.

ClearView Wealth Limited reported a solid 10% revenue increase for FY25 alongside a 126% jump in profit from continuing operations, yet net profit was tempered by losses from discontinued segments. The company paused its share buy-back program, signaling cautious capital management ahead.

Qoria Limited reported a robust FY2025 with 25% growth in annual recurring revenue and a 684% jump in EBITDA, underscoring its expanding leadership in global K12 safety and wellbeing platforms.

Perseus Mining Limited has announced an on-market buy-back program to repurchase up to 40 million ordinary shares over the next year, signaling a strategic move in capital management.

Nine Entertainment Co. Holdings Limited has announced a special fully franked dividend of AUD 0.49 per share, payable in late September 2025, signaling strong shareholder returns.